The University of Zurich, as well as all other universities belonging to the League of European Research Universities (LERU), emphasizes the entrepreneurial importance at universities in its advice paper from 2019.
In recent years, UZH launched various programs and institutions which support researchers in translating important life science discoveries into a change in clinical practice, new medications, diagnostics, or devices.
Have a look at UZH’s BioEntrepreneurship Ecosystem.
The UZH IncubatorLab provides UZH Entrepreneur Fellows with access to first-class research infrastructure for MedTech projects. The lab is hosted by the Institute of Regenerative Medicine · IREM.
Translational Development Accelerator
The Therapy Development Accelerator (TDA) is an academic translational centre at the University of Zurich with the mission to drive excellence in translational medicine and to support bioentrepreneurs who want to develop new promising therapies for patients with high unmet medical needs.
USZ Health Innovation Hub
The Health Innovation Hub is a key strategic initiative of the University Hospital Zurich to promote innovation and entrepreneurship in healthcare. By identifying and accelerating novel healthcare solutions, its foremost goal is to improve patients’ lives. The Health Innovation Hub provides a variety of support packages, personalized to the innovators’ needs, ranging from coaching, infrastructure to financing and more.
UZH Entrepreneur Fellowships in BioTech and MedTech
The UZH Entrepreneur Fellowships at the University of Zurich provide funding, training, lab facilities and expert advice to young researchers who intend to start up a company based on UZH research.
UZH Innovation Hub
The UZH Innovation Hub is a platform for innovation and entrepreneurship at the University of Zurich. It acts as a catalyst to accelerate the development of new inventions and ideas and strengthens the transfer of innovative research and teaching to the economy and society.
The Wyss Zurich is a joint accelerator of the University of Zurich and ETH Zurich (Swiss Federal Institute of Technology Zurich), which was made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. h.c. mult. Hansjörg Wyss. It was established to foster translational research focused on developing treatment protocols and clinical therapies, as well as novel technologies and intelligent systems, in the emerging fields of Regenerative Medicine and Robotics and related hybrid technologies.